Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. ПироговаfiledCriticalНаучно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. Пирогова
Priority to UAU201314523UpriorityCriticalpatent/UA89712U/en
Publication of UA89712UpublicationCriticalpatent/UA89712U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The method for treating osteoporosis in the patients with systemic lupus erythematosus comprises the use of calcium-containing drugs, vitamin D and the assay for homocysteine and transforming factor growth beta 1. If homocysteine content exceeds 15 µM and TGF-(1 is below 14 ng/mL, Ostegenon is provided at a dose of 2 tablets thrice a day for three months, then one tablet thrice a day for further three months and Decamevit is provided at a dose of one tablet twice a day, 20-day courses with 5-day intervals.
UAU201314523U2013-12-112013-12-11Method for treating osteoporosis in patients with systemic lupus erythematosus
UA89712U
(en)